Positron emission tomography in lung cancer
- PMID: 19367450
- DOI: 10.1007/s11748-008-0371-3
Positron emission tomography in lung cancer
Abstract
Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-D: -glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the prediction of its malignancy grade. However, FDG-PET has been known to have several pitfalls for imaging of lung cancer. For the effective clinical use of FDG-PET in lung cancer, we reviewed the pitfalls of using FDG-PET in the diagnosis of pulmonary nodules, semiquantitative analysis of FDG-uptake, N-staging, prediction of tumor aggressiveness, prognostic significance, and prediction of pathological response after chemoradiotherapy.
Similar articles
-
Lung cancer and positron emission tomography with fluorodeoxyglucose.Lung Cancer. 2000 Jun;28(3):187-202. doi: 10.1016/s0169-5002(00)00096-9. Lung Cancer. 2000. PMID: 10812188 Review.
-
Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.Acta Radiol. 2009 Jul;50(6):638-44. doi: 10.1080/02841850902971255. Acta Radiol. 2009. PMID: 19492198
-
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19. Acad Radiol. 2013. PMID: 22999369
-
The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.Radiother Oncol. 2000 Jun;55(3):317-24. doi: 10.1016/s0167-8140(00)00138-9. Radiother Oncol. 2000. PMID: 10869746
-
Role of FDG-PET in the diagnosis and management of lung cancer.Expert Rev Anticancer Ther. 2004 Aug;4(4):561-7. doi: 10.1586/14737140.4.4.561. Expert Rev Anticancer Ther. 2004. PMID: 15270660 Review.
Cited by
-
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.Med Oncol. 2012 Jun;29(2):589-94. doi: 10.1007/s12032-011-9879-y. Epub 2011 Mar 6. Med Oncol. 2012. PMID: 21380783
-
Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET/MRI in patients with non-small cell lung cancer.Ann Nucl Med. 2022 Dec;36(12):1059-1072. doi: 10.1007/s12149-022-01795-9. Epub 2022 Oct 20. Ann Nucl Med. 2022. PMID: 36264439
-
PET/CT imaging in lung cancer: indications and findings.J Bras Pneumol. 2015 May-Jun;41(3):264-74. doi: 10.1590/S1806-37132015000004479. J Bras Pneumol. 2015. PMID: 26176525 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical